CNS penetration of ARV drugs is associated with lower CSF viral load
25 March 2006. Related: Conference reports, Antiretrovirals.
Conference reports
Sexual transmission of hepatitis C in HIV-positive men in the UK
25 March 2006. Related: Conference reports, Hepatitis coinfection.
D:A:D study shows that PIs rather than NNRTIs drive the previously reported cardiovascular risk of combination antiretroviral therapy
25 March 2006. Related: Conference reports, Side effects.
Interventions for the management of lipodystrophy and metabolic complications
25 March 2006. Related: Conference reports, Side effects, Weight, diabetes, metabolic complications.
45th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), 16-19 December 2005, Washington, USA
16 March 2006. Related: Conference reports.
One third of HIV/HCV coinfected patients with normal ALT have advanced fibrosis in Spanish cohort
16 March 2006. Related: Conference reports, Hepatitis coinfection.
10th European AIDS Conference (EACS), 17-20 November 2005, Dublin, Ireland
11 February 2006. Related: Conference reports.
Rifaximin cure reported for cryptosporidium in advanced HIV
11 February 2006. Related: Conference reports, Coinfections and complications.
Analysis of hepatic events in 2NN study by CD4 entry criteria, levels differences between nevirapine and efavirenz; excess hepatic events in once-daily nevirapine arm linked to single site in Thailand
11 February 2006. Related: Conference reports, Side effects.
FTC studies at EACS: reduced incidence of M184V compared to 3TC; side effect profile in clinical practice
11 February 2006. Related: Conference reports, Antiretrovirals.
Paediatric studies at EACS: trends in antiretroviral use in the Madrid Cohort; life expectancy significantly increased HIV/HCV co-infected children since HAART; use of tenofovir in treatment experienced children; switching to lopinavir/r from double protease inhibitor regimen; once daily lopinavir/r, 3TC and abacavir; planned treatment interruptions in children
11 February 2006. Related: Conference reports, Paediatric care.
Efficacy of lopinavir/r in patients with advanced HIV (CD4 <25 cells/mm3)
11 February 2006. Related: Conference reports, Antiretrovirals.
Potential barriers to use of T-20: results from patient and physician interviews
11 February 2006. Related: Conference reports, Antiretrovirals.
Factors associated with sexual dysfunction in HIV patients
11 February 2006. Related: Conference reports, Side effects.
Decreased varicella zoster immunity in migrants from sub-Saharan Africa
11 February 2006. Related: Conference reports, Coinfections and complications.
Clinical experience of switching to atazanavir in the UKs largest clinic
11 February 2006. Related: Conference reports, Antiretrovirals.
Replacing a PI with atazanavir: separating swans from ducklings?
11 February 2006. Related: Conference reports, Antiretrovirals.
TMC 125: some good and bad news
11 February 2006. Related: Conference reports, Antiretrovirals.
When to change a failing regimen: second-line and salvage strategies
11 February 2006. Related: Conference reports, Antiretrovirals.
Antiretrovirals and other stuff!
11 February 2006. Related: Conference reports, Antiretrovirals.
Heart disease in people with HIV
11 February 2006. Related: Conference reports.
Mortality trends: why people with HIV die (or dont) today
11 February 2006. Related: Conference reports.
45th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), 16-19 December 2005, Washington, USA
10 February 2006. Related: Conference reports.
Understanding TMC114 power against resistant HIV
10 February 2006. Related: Conference reports, Antiretrovirals.
New antiretroviral compounds at ICAAC: new PI brecanavir from GSK; maturation inhibitor PA-457; antiviral activity of monoclonal antibody; TNX-355 in treatment experienced patients
10 February 2006. Related: Conference reports, Antiretrovirals.
Comparison of pharmacokinetics of originator and generic liquid formulations and split tablets in Malawian children
10 February 2006. Related: Conference reports, Paediatric care.
African-Americans in ACTG 5095 had shorter time to virologic failure and grade 3/4 side effects
10 February 2006. Related: Conference reports, Side effects.
Predictors of insulin resistance in first year of therapy
10 February 2006. Related: Conference reports, Side effects.
Three measures confirm 144-week renal record of tenofovir
10 February 2006. Related: Conference reports, Antiretrovirals.
Low rash risk with efavirenz after nevirapine rash
10 February 2006. Related: Conference reports, Antiretrovirals.
7th Workshop on Adverse Drug Reactions and Lipodystrophy in HIV, 13-16 November 2005, Dublin, Ireland
13 December 2005. Related: Conference reports.
Monitoring side effects in resource limited countries
13 December 2005. Related: Conference reports, Side effects.
Uridine supplement reverses thymidine-induced lipoatrophy
13 December 2005. Related: Conference reports, Side effects, Weight, diabetes, metabolic complications.
Pravastatin increases limb fat in HIV-positive patients with hypercholesterolaemia
13 December 2005. Related: Conference reports, Side effects, Weight, diabetes, metabolic complications.
Evidence that facial fat can return after switching from either d4T or AZT, to abacavir or tenofovir
13 December 2005. Related: Conference reports, Side effects, Weight, diabetes, metabolic complications.
Niacin has beneficial effect on lipids but no reduction in abdominal fat
13 December 2005. Related: Conference reports, Side effects, Weight, diabetes, metabolic complications.
Gluteal implants used to replace lost buttock fat
13 December 2005. Related: Conference reports, Side effects, Weight, diabetes, metabolic complications.
10th European AIDS Conference, 17-20 November 2005, Dublin, Ireland
13 December 2005. Related: Conference reports.
Pregnancy studies at EACS
13 December 2005. Related: Conference reports, Pregnancy.
Further Reports from 3rd IAS Conference on AIDS Pathogenesis and Treatment, Rio de Janeiro, Brazil, 24-27 July 2005
13 October 2005. Related: Conference reports.
Management of hepatitis C and B in HIV-coinfected individuals: an overview of studies presented at the 3rd IAS Conference
13 October 2005. Related: Conference reports, Hepatitis coinfection.
Highlights of HIV drug resistance studies presented at the 3rd IAS Conference
13 October 2005. Related: Conference reports, Drug resistance.
3rd IAS Conference on HIV Pathogenesis and Treatment, 24-27 July 2005, Rio de Janeiro, Brasil
14 September 2005. Related: Conference reports.
Adult male circumcision reduces transmission rates over 18 months comparable to a vaccine with 65% efficacy
14 September 2005. Related: Conference reports, HIV prevention and transmission.
Benefits of adding 4 or 7 days of AZT/3TC to single-dose nevirapine to prevent MTCT: further analysis from TOPS
14 September 2005. Related: Conference reports, Pregnancy.
New drugs in pregnancy: atazanavir; T20
14 September 2005. Related: Conference reports, Pregnancy.
Lopinavir/r use in children less than two years old promising results despite low plasma levels
14 September 2005. Related: Conference reports, Paediatric care.
Favourable outcomes in children treated with HAART in the MSF programmes
14 September 2005. Related: Conference reports, Paediatric care.
Encouraging results with cut up generic fixed dose combination tablets in Uganda
14 September 2005. Related: Conference reports, Paediatric care.
Predictors of survival at three years follow up for HIV-infected children in Cote D’Ivoire
14 September 2005. Related: Conference reports, Paediatric care.
Benefit of maintaining the M184V mutation with 3TC monotherapy: final 48-week results
14 September 2005. Related: Conference reports, Antiretrovirals.
T20 (enfuvirtide) studies presented at Rio
14 September 2005. Related: Conference reports.
Strategies for salvage therapy
14 September 2005. Related: Conference reports, Antiretrovirals.
Antiviral activity of foscarnet in salvage patients
14 September 2005. Related: Conference reports, Antiretrovirals.
Novel strategies with existing drugs
14 September 2005. Related: Conference reports, Antiretrovirals.
Antiretroviral activity of new and novel agents
14 September 2005. Related: Conference reports, Antiretrovirals.
Overview of pharmacology studies
14 September 2005. Related: Conference reports, PK and drug interactions.
Incidence of TB infection despite HAART and treatment in coinfected patients
14 September 2005. Related: Conference reports, TB coinfection.
Evaluation of ESAT-6 and CFP-10 as markers for response to TB treatment in HIV/TB coinfected patients
14 September 2005. Related: Conference reports, TB coinfection.
Does WHO clinical stage reliably predict who should receive ARV treatment?
14 September 2005. Related: Conference reports, Treatment access.
Continuous vs intermittent treatment with triple nuke combination of AZT/3TC/tenofovir in Africa: early results from DART study
14 September 2005. Related: Conference reports, Treatment access.
3rd IAS Conference on HIV Pathogenesis and Treatment, 24-27 July 2005, Rio de Janeiro, Brasil
14 August 2005. Related: Conference reports.
Keystone vaccine symposia 2005: vaccines, pathogenesis, snow and a couple of elk
14 August 2005. Related: Conference reports, Vaccines and microbicides.
14th International HIV Drug Resistance Workshop (14th IHDRW), 7-11 June 2005, Quebec City, Canada
15 July 2005. Related: Conference reports.
Genetic factors affecting HIV infection and progression rates: immunological factors relating to entry inhibitors
15 July 2005. Related: Conference reports, Basic science and immunology.